Benchmark lowered the firm’s price target on Green Thumb Industries (GTBIF) to $10 from $14 and keeps a Buy rating on the shares. Green Thumb delivered “strong” Q4 results, outperforming consensus on both revenue and AEBITDA despite sector-wide pricing pressure and regulatory uncertainty, the analyst tells investors. Pricing headwinds remain a challenge, but the company’s cash flow strength and strategic investments “provide a competitive edge,” the analyst argues.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTBIF:
- Green Thumb Industries to open RISE Dispensary Henderson in Nevada
- Strong Financial Performance and Strategic Expansion Drive Buy Rating for Green Thumb Industries
- Green Thumb Industries Reports Record Revenue and Expansion
- Green Thumb Industries Reports Strong 2024 Financial Results
- Green Thumb Industries Reports Strong Q4 2024 Financials